De la investigación a la acción en salud pública: factores favorables en América Latina

Los autores describen los principales problemas de salud en Latinoamérica y plantean la necesidad de desarrollar líneas de investigación sobre los mismos. Aparte de las consideraciones sobre este tema, que vale la pena leer, postulan que el traslado de la investigación a la acción en salud pública es altamente factible, dada la capacidad humana existente, los buenos recursos de tecnología y comunicaciones, etc. Es muy interesante que los mismos factores que tienden a convertirnos en factoría ejecutiva de diseños de investigación de las multinacionales farmacéuticas son aquellos que pueden contribuir a que desarrollemos investigación pertinente, válida y urgente.

Perel P, Casas JP, Ortiz Z, Miranda JJ (2006) Noncommunicable Diseases and Injuries in Latin America and the Caribbean: Time for Action. PLoS Med 3(9): e344 (ver en http://medicine.plosjournals.org/perlserv/?request…)

“In the LAC region, rapid translation of research investment into improved public health is highly feasible [21]. As a group of middle-income countries, the LAC countries have an adequate technology-communications infrastructure, as well as highly qualified health and academic human resources—essential for conducting high-quality human epidemiological research. Furthermore, LAC countries share a similar cultural identity, and most of the population shares a common language, which undoubtedly would strengthen regional initiatives in collaborative research. These favorable advantages, added to the low cost of conducting research in the region compared with the costs in developed countries, have been used by pharmaceutical companies to actively recruit LAC populations into randomized clinical trials. The number of US-based trials executed in LAC countries has increased over 10-fold from 1995 to 2000, making the LAC countries the fourth-largest clinical trial market [22]. Unfortunately, these clinical trials often do not address diseases with a great burden to the region (e.g., mental health, chronic respiratory disease, and trauma). In addition, trials conducted in the LAC population, while sometimes addressing relevant pathologies such as cardiovascular disease, usually involve interventions that would not be affordable to LAC populations or that would be difficult to implement in settings with inadequate health-care resources [22].”

LJ

Anuncios

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s


A %d blogueros les gusta esto: